CHO Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	11,685	6,014	11,022	14,830	25,204	15,354
Market Cap Growth	23.67%	-45.44%	-25.68%	-41.16%	64.15%	235.65%
Enterprise Value	9,639	3,809	8,568	13,944	24,033	13,969
Last Close Price	54.60	28.10	51.50	69.30	137.00	83.50
PS Ratio	8165.60	4202.44	3078.64	-	420067.12	4300.98
PB Ratio	4.74	2.44	4.01	4.99	17.64	8.80
P/TBV Ratio	5.72	2.94	4.74	5.83	27.06	12.44
EV/Sales Ratio	-	2661.50	2393.25	-	400545.33	3912.99
Debt / Equity Ratio	0.01	0.01	0.01	-	0.01	0.02
Net Debt / Equity Ratio	-0.83	-0.83	-0.85	-0.87	-0.72	-0.74
Net Debt / EBITDA Ratio	6.84	6.84	9.83	10.40	3.18	6.99
Net Debt / FCF Ratio	7.08	7.08	10.49	8.88	3.99	6.59
Asset Turnover	0.00	0.00	0.00	-	0	0.00
Quick Ratio	18.96	18.96	20.41	24.57	6.19	9.89
Current Ratio	19.47	19.47	20.81	24.93	6.39	10.06
Return on Equity (ROE)	-11.13%	-11.13%	-7.41%	-13.90%	-21.33%	-11.11%
Return on Assets (ROA)	-7.47%	-7.47%	-5.22%	-7.17%	-12.55%	-6.52%
Return on Capital Employed (ROCE)	-13.20%	-13.20%	-9.00%	-9.00%	-24.50%	-12.00%
Earnings Yield	-2.48%	-4.82%	-1.93%	-2.06%	-1.34%	-1.34%
FCF Yield	-2.47%	-4.80%	-2.02%	-1.98%	-1.03%	-1.28%
Buyback Yield / Dilution	0.53%	0.36%	-11.86%	-4.00%	-0.04%	-0.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.